FDA approval of Utibron Neohaler is great news for COPD patients
from By Dr. Abimbola Farinde
Chronic obstructive pulmonary disease, or COPD, is regarded as a progressive and life-threatening lung disease that can make it a challenging for an individual to breathe. There are a variety of respiratory agents for the management of COPD, and the recent FDA approval of Utibron Neohaler offers another option. Utibron Neohaler is an important approval as it offers a new dual-action bronchodilator option for patients and the potential for better quality of life.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063